Dr. Christopher Shade obtained B.S. and M.S. degrees from Lehigh University in environmental and aqueous chemistry. Dr. Shade earned a Ph.D. from the University of Illinois where he studied the environmental and analytical chemistries of mercury as well as advanced aquatic chemistry. During his Ph.D. work, Dr. Shade patented analytical technology for mercury speciation analysis and later founded Quicksilver Scientific, LLC in order to commercialize this technology.
Shortly after starting Quicksilver Scientific, Dr. Shade turned his focus to the human aspects of mercury exposure/toxicity and the human detoxification system. He has since developed specific clinical analytical techniques for measuring mercury exposure and a system of products to remove metallic and organic toxins by upregulation of innate detoxification biochemistry. His current focus is at the intersection of neuroinflammatory issues, immune dysregulation, toxicity, and infection – specifically how to peel away the layers of overlapping dysfunction in the sick individual until you get to a point at which the system rights itself.
|ID||Event Name||Duration||Start Date|
|UE-1679||AutismOne Virtual Summit||32 Weeks||May 20, 2020|
|UE-918||Heavy Metals Summit||48 Weeks||January 29, 2018|
|UE-650||The Immune Defense Summit||23 Weeks||July 24, 2017|
|UE-367||The Autoimmune Revolution 2017||48 Weeks||January 30, 2017|
|UE-152||The Alzheimer’s and Dementia Summit||66 Weeks||July 25, 2016|
|UE-539||Autism Recovery Summit 2||104 Weeks||January 1, 2016|